Sansure Biotech Inc (688289) — Cash Flow Quality Index
Sansure Biotech Inc (688289) has a Cash Flow Quality Index of 2.09x as of September 2025. Operating cash flow of CN¥59.72 Million exceeds net income of CN¥28.60 Million, indicating high earnings quality where cash backs reported profits. Also explore Sansure Biotech Inc balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sansure Biotech Inc Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Sansure Biotech Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Sansure Biotech Inc (688289) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sansure Biotech Inc (2018–2025)
Year-by-year earnings quality comparison for Sansure Biotech Inc. For live market cap and the full company financial profile, see 688289 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.93x | CN¥183.96 Million | CN¥198.15 Million | ▼ -23.5% |
| 2024 | 1.21x | CN¥274.45 Million | CN¥226.27 Million | ▲ +274.3% |
| 2023 | 0.32x | CN¥112.82 Million | CN¥348.17 Million | ▼ -75.5% |
| 2022 | 1.32x | CN¥2.56 Billion | CN¥1.94 Billion | ▲ +57.9% |
| 2021 | 0.84x | CN¥1.88 Billion | CN¥2.24 Billion | ▼ -17.1% |
| 2020 | 1.01x | CN¥2.64 Billion | CN¥2.62 Billion | ▲ +77.9% |
| 2019 | 0.57x | CN¥22.41 Million | CN¥39.48 Million | ▼ -61.9% |
| 2018 | 1.49x | CN¥10.07 Million | CN¥6.76 Million | — |